COMMUNIQUÉS West-GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2025
15/10/2025
Aggregated presentation by day and by market Statement of transactions in own shares from October 06th to October 10th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 41 - 2025
15/10/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 06 Octobre au 10 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic
15/10/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, [...]
Eascra Biotech Named to Fast Company’s “Next Big Things in Tech 2025”
15/10/2025
Recognition for groundbreaking work and pioneering space manufacturing BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next Big Things in Tech list [...]
Ketabon Presents New Data Showing Antidepressant Effects of Oral Ketamine (KET01) Are Independent of Dissociation
15/10/2025
Findings Presented at ECNP 2025 in Amsterdam Support the Potential for a Safe At-Home Treatment Option in Treatment-Resistant Depression MUNICH, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company [...]
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
15/10/2025
Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life WeightWatchers Members Lost 21% of Their Body Weight, Outperforming Results by Other Telehealth Providers NEW [...]
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio
15/10/2025
Collaboration and license agreement will advance Boehringer’s expanding antibody-drug conjugate (ADC) portfolio with a new asset expected to enter first-in-human studies next year . New, potentially best-in-class ADC is [...]
Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
15/10/2025
NMPA’s response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage drug [...]
Extendicare Announces October 2025 Dividend of C$0.042 per Share
15/10/2025
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of [...]
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
15/10/2025
Seasoned clinician and R&D leader brings extensive experience in translational medicine, drug development, and infectious disease research WESTLAKE VILLAGE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Step Pharma announces completion of €38 million Series C financing
15/10/2025
Financing will support the Company’s ongoing clinical development of its lead asset, dencatistat, across multiple indications Round led by new investor V-Bio Ventures, with participation from existing investors Pontifax [...]
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
15/10/2025
OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) [...]
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
15/10/2025
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report [...]
Rezolute to Participate in Upcoming Investor Conferences
15/10/2025
REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Canada’s Largest Family Medicine Gathering Comes to Winnipeg This November
15/10/2025
Focused on advancing patient care through education, collaboration, and innovation Event Information: Family Medicine Forum November 5–8, 2025 (Winnipeg) fmf.cfpc.ca MISSISSAUGA, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE [...]
Le plus grand rassemblement de médecins de famille au pays posera ses valises à Winnipeg en novembre
15/10/2025
Centré sur l’amélioration des soins aux patients grâce à l’éducation, à la collaboration et à l’innovation Information sur l’événement : Forum en médecine familiale Du 5 au 8 novembre 2025 (Winnipeg) fmf.cfpc.ca/fr/ [...]
Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
15/10/2025
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate Methodologies (NAM)-based patient-derived tumoroid [...]
Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
15/10/2025
Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical management HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic [...]
Noom Introduces “Mindful Art Break” — A Weekly Practice Designed to Spark Awe, Relieve Stress, and Boost Psychological Wellbeing
15/10/2025
Noom open sources wellbeing by releasing its art-impact research, AI art-scoring tools, and the A.R.T. (Art Research Tool) into the public domain PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Noom , the leading [...]

Pages